Look for:

Our offer for

BRISTOL-MYERS SQUIBB CO.


ISIN:
US1101221083
WKN:
110122108

2021/10/26 20:36:12
Price
58.095 USD
Difference 0.49% (0.28)

General attributes

ISINUS1101221083
SymbolBMY
ExchangeNYSE
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)110,675 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)58.09 USD (1,000)
Ask (Ask size)58.10 USD (900)
Open57.90 USD
High58.13 USD
Low57.62 USD
Close (prev. day)57.81 USD
VWAP57.938328 USD
Volume (pcs)6,118,626
Trading volume354,475,029.99
Number of trades49,247
Last size100

Futures and Options

Related Futures15
Related Options-

PDF Downloads

Company report: BRISTOL-MYERS SQUIBB CO.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2021/10/26 20:36:12
Price
58.095 USD
Difference 0.49% (0.28)

General attributes

ISINUS1101221083
SymbolBMY
ExchangeNYSE
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)110,675 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)58.09 USD (1,000)
Ask (Ask size)58.10 USD (900)
Open57.90 USD
High58.13 USD
Low57.62 USD
Close (prev. day)57.81 USD
VWAP57.938328 USD
Volume (pcs)6,118,626
Trading volume354,475,029.99
Number of trades49,247
Last size100

Performance and Risk

6m1Y3Y
Perf (%)-12.42%-3.86%+17.48%
Perf (abs.)-8.20-2.32+8.60
Beta0.450.600.64
Volatility16.9219.8725.89
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)57.776 USD (8,432,003)
Ø price 30 days | Ø volume 30 days (pcs.)59.148 USD (11,203,406)
Ø price 100 days | Ø volume 100 days (pcs.)64.598 USD (9,421,596)
Ø price 250 days | Ø volume 250 days (pcs.)63.577 USD (10,592,722)
YTD High | date69.750 USD (2021/08/23)
YTD Low | date56.660 USD (2021/10/13)
52 Weeks High | date69.750 USD (2021/08/23)
52 Weeks Low | date56.660 USD (2021/10/13)

All listings for BRISTOL-MYERS SQUIBB CO.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2021/10/2617:3550.06 EUR0.2068
Vienna Stock Exchange2021/10/2517:2849.88 EUR0.064
Tradegate2021/10/2620:3550.01 EUR0.3875
Stuttgart2021/10/2619:2550.00 EUR0.007
SIX Swiss Exchange2019/07/0305:5545.30 USD0.001
SIX Swiss Exchange2019/06/2417:3144.50 CHF0.054
NYSE2021/10/2620:3658.095 USD354.4849,247
Munich2021/10/2608:0249.51 EUR0.001
London Stock Exchange European Trade Reporting2021/10/2617:3058.02 USD0.008
Hanover2021/10/2608:0149.465 EUR0.001
Hamburg2021/10/2611:0250.03 EUR0.004
Frankfurt2021/10/2616:4549.90 EUR0.056
Duesseldorf2021/10/2619:3049.975 EUR0.0010
Berlin2021/10/2608:0249.51 EUR0.001

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=716&ID_TYPE_IMAGE_LOGO=2

Contact Details

BRISTOL MYERS SQUIBB CO.
- -
430 East 29th Street - 10016 New York
Telefon: 1-212-546-4000
Fax: -
E-mail: -

PDF Downloads

Company report: BRISTOL-MYERS SQUIBB CO.PDF Download

Company Profile

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in New York, NY.

Members of Management Board

Julia HallerMember of Board of Directors
Karen VousdenMember of Board of Directors
Manuel Hidalgo MedinaMember of Board of Directors
Derica RiceMember of Board of Directors
Gerald StorchMember of Board of Directors
Paula PriceMember of Board of Directors
Peter ArduiniMember of Board of Directors
Phyllis YaleMember of Board of Directors
Theodore SamuelsMember of Board of Directors
Giovanni CaforioChairman of Managing Board
Christopher BoernerMember of Executive Committee
Adam DubowMember of Executive Committee
Ann M. PowellMember of Executive Committee
Catalina VargasMember of Executive Committee
David ElkinsMember of Executive Committee
Elizabeth A. MilyMember of Executive Committee
Joseph E. EidMember of Executive Committee
Lou SchmuklerMember of Executive Committee
Michelle WeeseMember of Executive Committee
Paul von AutenriedMember of Executive Committee
Rupert VesseyMember of Executive Committee
Samit HirawatMember of Executive Committee
Sandra LeungMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. For more details please read our Data protection policy.

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer